These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10792258)

  • 1. Successful treatment using clarithromycin for a cutaneous lesion caused by Mycobacterium szulgai.
    Shimizu T; Kodama K; Kobayashi H; Ohkawara A; Ogawa K; Taniguchi S
    Br J Dermatol; 2000 Apr; 142(4):838-40. PubMed ID: 10792258
    [No Abstract]   [Full Text] [Related]  

  • 2. Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus.
    Kishida D; Sato M; Kobayashi C; Ueno KI; Kinoshita T; Kodaira M; Shimojima Y; Ishii W; Ushiki A; Ikeda SI
    Intern Med; 2017; 56(10):1253-1257. PubMed ID: 28502947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection.
    Painsi C; Lange-Asschenfeldt B
    Br J Dermatol; 2017 Jul; 177(1):e1. PubMed ID: 28731256
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection.
    Driscoll MS; Tyring SK
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):495-6. PubMed ID: 9091495
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells.
    Valencia IC; Weiss E; Sukenik E; Kerdel FA
    Int J Dermatol; 1999 Oct; 38(10):770-3. PubMed ID: 10561050
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti-tumor necrosis factor-alfa agents.
    Caron J; Michot C; Fabre S; Godreuil S; Guillot B; Dereure O
    J Am Acad Dermatol; 2011 Nov; 65(5):1060-2. PubMed ID: 22000874
    [No Abstract]   [Full Text] [Related]  

  • 7. Disseminated cutaneous Mycobacterium chelonae infection.
    Kane CL; Vincent AL; Greene JN; Sandin RL
    Cancer Control; 2000; 7(2):181-4. PubMed ID: 10783823
    [No Abstract]   [Full Text] [Related]  

  • 8. Epithelioid histiocytic infiltrate caused by Mycobacterium scrofulaceum infection: a potential mimic of various neoplastic entities.
    Lai J; Abbey BV; Jakubovic HR
    Am J Dermatopathol; 2013 Apr; 35(2):266-9. PubMed ID: 22935892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
    Tebas P; Sultan F; Wallace RJ; Fraser V
    Clin Infect Dis; 1995 Feb; 20(2):443-4. PubMed ID: 7742453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous infection with Mycobacterium marinum. successful therapy with rifampicin and clarithromycin].
    Brans R; Rübben A; Poblete-Gutiérrez P
    Hautarzt; 2004 Jan; 55(1):76-9. PubMed ID: 14749869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen.
    Nagore E; Ramos P; Botella-Estrada R; Ramos-Níguez JA; Sanmartín O; Castejón P
    Acta Derm Venereol; 2001; 81(4):291-3. PubMed ID: 11720180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresolving furunculosis in a diabetic patient: cutaneous Mycobacterium abscessus infection.
    Lee HY; Bee YM; Thirumoorthy T
    Ann Acad Med Singap; 2009 Feb; 38(2):166-7. PubMed ID: 19271048
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous Mycobacterium chelonae infection presenting as symmetrical plaques on both shins in an immunocompetent patient.
    Chung WK; Kim MS; Kim CH; Lee MW; Choi JH; Moon KC; Koh JK
    Acta Derm Venereol; 2009 Nov; 89(6):663-4. PubMed ID: 19997711
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin.
    Franck N; Cabié A; Villette B; Amor B; Lessana-Leibowitch M; Escande JP
    J Am Acad Dermatol; 1993 Jun; 28(6):1019-21. PubMed ID: 8496448
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.
    Parize P; Hamelin A; Veziris N; Morand PC; Guillemain R; Lortholary O; Dupin N
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):101-5. PubMed ID: 25677464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nodular skin lesions in a patient with rheumatoid arthritis under therapy with anti-tumor necrosis factor-α].
    Díaz Cuevas Z; Rodríguez-Lozano B; Campos Gutierrez S; Lecuona Fernández M
    Med Clin (Barc); 2014 Feb; 142(4):183-4. PubMed ID: 23877097
    [No Abstract]   [Full Text] [Related]  

  • 17. Disseminated cutaneous Mycobacterium chelonae.
    Shim TN; Lew TT; Preston PW
    Lancet Infect Dis; 2012 Mar; 12(3):254. PubMed ID: 22361431
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of subcutaneous nodules after mesotherapy].
    Ramos A; Roustan G; Lucena JL; Daza RM
    Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):775-7. PubMed ID: 21722998
    [No Abstract]   [Full Text] [Related]  

  • 19. Clarithromycin: a potent agent against infections due to Mycobacterium marinum.
    Bonnet E; Debat-Zoguereh D; Petit N; Ravaux I; Gallais H
    Clin Infect Dis; 1994 Apr; 18(4):664-6. PubMed ID: 8038339
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous Mycobacterium chelonae in a 95-year-old woman.
    Neal D; Taylor S; Taylor M
    Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.